Concepedia

Brian Ko

BK

8

Publications

565

Citations

8

H-Index

2010

Active since

Affiliations

NGM Biopharmaceuticals (United States)(Current)

Cedars-Sinai Medical Center

Istituto Tumori Bari

University of Bologna

University of Bari Aldo Moro

Brian Ko is an author at NGM Biopharmaceuticals (United States) specializing in autoimmunity, pathology, and immune regulation.

Top concepts

Publications per year

2010–2020

8

Publications

8

A nontumorigenic variant of FGF19 treats cholestatic liver diseases

Jian Luo, Brian Ko, M Elliott et al. · Science Translational Medicine · 2014 · 165 citations

Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor

Raffaella Maria Gadaleta, Oihane García‐Irigoyen, Marica Cariello et al. · EBioMedicine · 2020 · 109 citations · Full text

Constitutive TL1A (TNFSF15) Expression on Lymphoid or Myeloid Cells Leads to Mild Intestinal Inflammation and Fibrosis

David Q. Shih, Robert J. Barrett, Xiaolan Zhang et al. · PLoS ONE · 2011 · 97 citations · Full text

, , +17

Circulating FGF19 closely correlates with bile acid synthesis and cholestasis in patients with primary biliary cirrhosis

Zhanyi Li, Bingliang Lin, Guoli Lin et al. · PLoS ONE · 2017 · 57 citations · Full text

Suppression of Hepatic Bile Acid Synthesis by a non-tumorigenic FGF19 analogue Protects Mice from Fibrosis and Hepatocarcinogenesis

Raffaella Maria Gadaleta, Natasha Scialpi, Cláudia Maria Peres et al. · Scientific Reports · 2018 · 52 citations · Full text

Rows per page

1–5 of 8